Figure 3.
Roles of m6A in myeloid leukemogenesis. In the process of myeloid leukemogenesis, multiple m6A regulators play oncogenic roles (green arrows) at different stages of leukemogenesis. METTL3 and METTL14 promote the self-renewal/proliferation of leukemia stem cells/leukemia-initiating cells (LSCs/LICs) and the proliferation/survival of leukemia cells. The RBM15-MKL1 fusion protein plays a role in acute megakaryoblastic leukemia, facilitating the transformation of megakaryocytes and inducing a differentiation bias toward the megakaryocytic lineage. WTAP promotes the proliferation of leukemia cells. FTO and ALKBH5 promote the transformation of HSCs to LSCs/LICs, maintain the self-renewal capacity of LSCs/LICs, and are required for the survival/proliferation of leukemia cells. YTHDF2 is essential for leukemia initiation and the functional integrity of LSCs/LICs. The identified downstream effectors (signaling pathways and target proteins) or mediator proteins that are critical for the function of m6A regulators are listed (in italics).